Affiliation:
1. HARRAN ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
2. TARSUS ÜNİVERSİTESİ, SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU, ECZANE HİZMETLERİ BÖLÜMÜ
3. MERSİN ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
4. MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ
5. KOÇ ÜNİVERSİTESİ
Abstract
Purpose: Coronary artery disease is defined as complications that develop in proportion to the prevalence of ischemia due to occlusion of the coronary arteries and the resulting cell death. The development of atherosclerosis is significantly influenced by endothelial cell dysfunction. Kruppel-like factor 2, a transcription factor, has been shown to regulate critical biological events in endothelial biology, such as vascular tone, migration, proliferation, vasoreactivity, and angiogenesis. In our study, it was aimed to clarify the relationship between coronary artery disease and Kruppel-like factor 2 protein levels and C1239A polymorphisms.
Materials and Methods: 191 individuals who underwent coronary angiography at Mersin University Faculty of Medicine, Department of Cardiology, Health, Research and Application Center were included in the study. Measurements of serum fasting blood glucose, HDL cholesterol, total cholesterol, and triglyceride levels were performed on the AU5800 (Beckman Coulter, United States) autoanalyzer. Serum LDL levels were calculated using the Friedwald equation. Serum Kruppel-like factor 2 protein levels were measured by sandwich enzyme-linked immunoassay method on the Multiskan GO (Thermo Scientific, Finland) device. Kruppel-like factor 2 C1239A variations were detected on the Applied Biosystem VIIA™ 7 Real-Time PCR (Life Technologies Co., United States) device by TaqMan® single nucleotide polymorphism (SNP) genotyping method.
Results: Men had a 3.8-fold higher risk of CAD than women. (Odd’s ratio 3.83, 95% Confidence interval 1.98-7.39; p
Funder
Mersin Üniversitesi Bilimsel Araştırma Projeleri Birimi
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference31 articles.
1. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol. 2010;56:50-103.
2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJS et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891-975.
3. Robert E, Rozensweig G, Rozensweig A. Principles of Molecular Medicine. 1st ed. New Jersey, USA: Humana Press Tawata, 1998;133-40.
4. Fuster V. Lewis A. Conner memorial lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1995;91:256-64.
5. Karabacak A, Özhan H. Atherosclerotic risk factors-I: Genetic, physiological and other features. Turkiye Klinikleri J Cardiol-Special Topics. 2011;4:19-24 (in Turkish with an abstract in English).